Related Experiment Video
Updated: Jul 8, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
[Cytology and DNA HPV-testing in the era of HPV-vaccine]
Marek Spaczyński1, Blanka Malkowska-Walczak, Ewa Nowak-Markwitz
1Klinika Onkologii Ginekologicznej Katedry Ginekologii i Połoznictwa Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu. ptgms@gpsk.am.poznan.pl
Abstract:
Human papillomavirus (HPV) persistent infection is the main factor leading to the cervical cancer carcinogenesis. Wide-spread public vaccination against HPV as primary prevention is expected to reduce cervical cancer incidence and mortality rates. It is essential to bear in mind that screening for precancerous lesions cannot be discontinued because vaccination will not protect the patients against HPV types which have not been included in the first and second generation of vaccines.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Karyotyping
DNA Helicases
Genital Herpes
Herpes
